Disposition of soy isoflavones in normal human breast tissue

108Citations
Citations of this article
148Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Background: Despite decades of research on the relation between soy and breast cancer, questions regarding the absorption, metabolism, and distribution of isoflavones in breast tissue largely remain unanswered. Objective: We evaluated the potential health effects of isoflavone consumption on normal breast tissue; isoflavone concentrations, metabolites, and biodistribution were investigated and compared with 17β-estradiol exposure. Design: In this dietary intervention study, healthy women were randomly allocated to a soy milk (n = 11; 16.98-mg genistein and 5.40-mg daidzein aglycone equivalents per dose), soy supplement (n = 10; 5.27-mg genistein and 17.56-mg daidzein aglycone equivalents per dose), or control (n = 10) group. After a run-in period ≥4 d, 3 doses of soy milk or soy supplements were taken daily for 5 d before an esthetic breast reduction. Blood and breast biopsies were collected during surgery and analyzed with liquid chromatography-tandem mass spectrometry. Results: After soy administration, genistein and total daidzein concentrations, which were expressed as aglycone equivalents, ranged from 135.1 to 2831 nmol/L and 105.1 to 1397 nmol/L, respectively, in hydrolyzed serum and from 92.33 to 493.8 pmol/g and 22.15 to 770.8 pmol/g, respectively, in hydrolyzed breast tissue. The major metabolites identified in nonhydrolyzed samples were genistein-7-O-glucuronide and daidzein-7-O-glucuronide, with an overall glucuronidation of 98%. Total isoflavones showed a breast adipose/glandular tissue distribution of 40:60, and their mean (±SEM) derived 17β-estradiol equivalents toward estrogen receptor b were 21 ± 4-fold and 40 ± 10-fold higher than the 17β-estradiol concentrations in adipose (0.283 ± 0.089 pmol/g, P = 0.001) and glandular (0.246 ± 0.091 pmol/g, P = 0.001) fractions, respectively. Conclusion: After intake of soy milk and soy supplements, isoflavones reach exposure levels in breast tissue at which potential health effects may occur. © 2010 American Society for Nutrition.

Cite

CITATION STYLE

APA

Bolca, S., Urpi-Sarda, M., Blondeel, P., Roche, N., Vanhaecke, L., Possemiers, S., … Depypere, H. (2010). Disposition of soy isoflavones in normal human breast tissue. American Journal of Clinical Nutrition, 91(4), 976–984. https://doi.org/10.3945/ajcn.2009.28854

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free